CPT 90296 Diphtheria Antitoxin Reimbursement

CPT code 90296 denotes diphtheria antitoxin, an equine-derived antitoxic serum used to prevent or treat diphtheria by neutralizing circulating toxin. Nationally, this code is relevant for acute care clinicians, hospital billing departments, and payers managing coverage for a rare but high-acuity intervention. The code captures administration of a biologic product that is typically used in inpatient or emergency settings where observation for hypersensitivity is required.

Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical indications and service context for 90296, plus a summary of payer coverage considerations and coding practice themes. The publication outlines typical sites of service, common billing modifiers provided in the input, and notes on where input data are incomplete.

This briefing is intended to provide national-level context: what the code represents, why it matters in acute care billing, and what billing teams and policy analysts should expect when encountering claims for equine diphtheria antitoxin. Data not available in the input are identified where applicable.

Billing Code Overview

CPT code 90296 represents diphtheria antitoxin, a sterile aqueous solution of refined and concentrated proteins (chiefly globulins) containing antitoxic antibodies derived from the blood serum of horses (equine) immunized against diphtheria toxin. The product is used to prevent or treat diphtheria by providing passive immunization to neutralize circulating toxin.

Service type: Antitoxin administration for treatment or prophylaxis of diphtheria.

Typical site of service: Hospital inpatient or emergency department, and other acute care settings where rapid administration of antitoxin and monitoring for adverse reactions are available.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and detailed service line information.

Clinical Context

A 7-year-old child presents to the emergency department with a 24-hour history of progressive pharyngitis, fever, and a grayish pseudomembrane on the tonsils after travel to a region with low diphtheria immunization coverage. The emergency physician evaluates airway patency, obtains a throat culture and rapid swab, and in consultation with infectious disease and public health officials orders diphtheria antitoxin for immediate administration while awaiting confirmatory testing. The antitoxin is obtained from a regional public health stock, prepared by pharmacy under sterile conditions, and administered intravenously in monitored inpatient or ED observation settings with airway management and cardiac monitoring available due to risk of hypersensitivity and serum sickness.

Coding Specifications

Modifier	Description	When to Use
`00`	General reporting default (no modifier)	Use when no specific modifier applies and the service is billed as usual
`22`	Unusual procedural services	Use when administration required significantly greater effort or resources than typical (e.g., complex airway management concurrent with antitoxin administration)

Taxonomy Code	Specialty	Notes
207RH0000X	Infectious Disease	Specialist consulted for diagnosis and antitoxin indication/dosing
207L00000X	Emergency Medicine	ED physicians commonly initiate antitoxin administration and airway stabilization
207K00000X	Pediatrics	Pediatricians manage children presenting with suspected diphtheria and coordinate inpatient care
363A00000X	Clinical Laboratory	Laboratory specialists perform confirmatory microbiology testing and serology
3336C0002X	Pharmacist	Clinical pharmacists prepare and verify antitoxin dosing and dilution

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`J0690`	Injection, immune globulin, (for example, intravenous IG), non-specific, 500 mg	May be used for supportive immune globulin therapy in severe toxin-mediated disease when indicated
`36415`	Collection of venous blood by venipuncture	Performed to obtain cultures, serology, and baseline labs before or after antitoxin administration
`87070`	Culture, bacterial, any other source, other than urine, aerobic and anaerobic; culture	Throat or tissue cultures for Corynebacterium diphtheriae to confirm diagnosis
`99223`	Initial hospital care, typically 70 minutes or more, per day, for the evaluation and management of a patient, admitted to the hospital	Used for initial inpatient admission and complex care when antitoxin administration requires hospitalization
`31500`	Intubation, endotracheal, emergency procedure	Performed when airway compromise from diphtheritic pseudomembrane requires airway protection during antitoxin therapy

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`A36.0`	Diphtheria of nasal mucous membrane	Primary cause of diphtheria infection; indicates antitoxin use when toxin-mediated disease suspected
`A36.1`	Diphtheria of pharynx and tonsils	Common presentation requiring antitoxin to neutralize circulating toxin and prevent systemic complications
`A36.2`	Diphtheria of larynx and trachea	Airway-threatening disease where antitoxin and airway management are critical
`A36.3`	Diphtheria of other sites	Used when diphtheria affects atypical locations; antitoxin indicated for systemic toxin effects
`A36.8`	Other forms of diphtheria	Miscellaneous diphtheria diagnoses where antitoxin may be required
`A36.9`	Diphtheria, unspecified	Used when diphtheria is diagnosed but site not specified; antitoxin considered based on clinical severity

OpenPayer

Summary & Overview

CPT 90296: Diphtheria Antitoxin (Equine)